Allogene Therapeutics Inc (NASDAQ: ALLO) Spiked 0.68% In 6 Months Getting Ready For What’s Next
Allogene Therapeutics Inc (NASDAQ:ALLO)’s traded shares stood at 1.9 million during the last session, with the company’s beta value hitting 0.81. At the close of